Published in J Epidemiol Community Health on November 01, 2005
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care (1998) 4.49
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Cause-specific mortality in a population-based study of diabetes. Am J Public Health (1991) 2.89
All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox". Diabetes Care (2002) 2.22
Mortality among diabetics in a national sample. Am J Epidemiol (1988) 2.03
Cancer mortality among diabetics. J Natl Cancer Inst (1970) 2.03
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control (2004) 1.74
Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol (2005) 1.69
Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care (2000) 1.61
Mortality during 25 years of follow-up of a cohort with diabetes. Int J Epidemiol (1996) 1.58
Inequities in access to and utilisation of primary medical care services for Maori and low income New Zealanders. N Z Med J (1996) 1.56
Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control (1998) 1.50
Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control (2004) 1.45
Cigarette smoking and risk of type 2 diabetes mellitus among middle-aged and elderly Japanese men and women. Am J Epidemiol (2004) 1.25
All-cause mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population. Diabetes Care (2001) 1.17
Cause-specific mortality in a cohort of patients with diabetes mellitus: a population-based study in Sweden. J Clin Epidemiol (2001) 0.99
Mortality and causes of death in type 2 diabetic patients. A long-term follow-up study in Osaka District, Japan. Diabetes Res Clin Pract (1989) 0.98
Timing of weight gain in relation to breast cancer risk. Ann Oncol (1995) 0.91
Under-reporting of diabetes on death certificates among a population with diabetes in Otago Province, New Zealand. N Z Med J (2004) 0.87
Cause-specific and total mortality in the Canterbury (New Zealand) insulin-treated Diabetic Registry population: a 15-year follow-up study. Diabet Med (2003) 0.84
HbA1c screening for undiagnosed diabetes in New Zealand. Diabetes Metab Res Rev (2005) 0.83
Diabetes, insulin therapy, and colorectal cancer. BMJ (2005) 0.83
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
[Corporate influences on epidemiology]. Epidemiol Prev (2008) 4.59
Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study. Lancet (2009) 3.52
Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe. Epidemiology (2007) 2.60
Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children. Am J Respir Crit Care Med (2006) 2.56
Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol (2010) 2.48
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J (2012) 2.37
The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol (2007) 2.30
Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest (2009) 1.98
Gender differences in occupational exposure patterns. Occup Environ Med (2011) 1.72
Socio-economic factors and mortality among 25-64 year olds followed from 1991 to 1994: the New Zealand Census-Mortality Study. N Z Med J (2002) 1.70
Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC). Int J Epidemiol (2004) 1.68
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67
SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clin Cancer Res (2008) 1.66
Is hypertension associated with job strain? A meta-analysis of observational studies. Occup Environ Med (2013) 1.60
Occupation and bladder cancer among men in Western Europe. Cancer Causes Control (2003) 1.54
Can bacterial endotoxin exposure reverse atopy and atopic disease? J Allergy Clin Immunol (2004) 1.54
Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand. Aust N Z J Public Health (2008) 1.52
A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care (2008) 1.48
Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. Haematologica (2005) 1.48
Commentary: The end of the hygiene hypothesis? Int J Epidemiol (2008) 1.45
Feasibility of recruiting a birth cohort through the Internet: the experience of the NINFEA cohort. Eur J Epidemiol (2007) 1.42
A test-negative design with additional population controls can be used to rapidly study causes of the SARS-CoV-2 epidemic. Epidemiology (2020) 1.40
Can the prevalence of diagnosed diabetes be estimated from linked national health records? The validity of a method applied in New Zealand. J Prim Health Care (2011) 1.39
Mortality rates according to occupation in New Zealand males: 2001-2005. N Z Med J (2011) 1.39
Commentary: Representativeness is usually not necessary and often should be avoided. Int J Epidemiol (2013) 1.37
Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect (2009) 1.37
Prevention and control of diabetes in Pacific people. BMJ (2003) 1.36
European experience of laparoscopic major hepatectomy. J Hepatobiliary Pancreat Sci (2013) 1.33
Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health (2004) 1.30
National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) (2012) 1.30
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29
Asthma and the westernization 'package'. Int J Epidemiol (2002) 1.25
Self-reported truck traffic on the street of residence and symptoms of asthma and allergic disease: a global relationship in ISAAC phase 3. Environ Health Perspect (2009) 1.23
Case-control studies: basic concepts. Int J Epidemiol (2012) 1.20
Compression, expansion, or dynamic equilibrium? The evolution of health expectancy in New Zealand. J Epidemiol Community Health (2004) 1.19
Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immunol (2009) 1.19
Invited commentary: is indoor mold exposure a risk factor for asthma? Am J Epidemiol (2003) 1.18
Complications with Angio-Seal™ vascular closure devices compared with manual compression after diagnostic cardiac catheterization and percutaneous coronary intervention. J Interv Cardiol (2013) 1.13
Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol (2009) 1.11
Complexity, simplicity, and epidemiology. Int J Epidemiol (2006) 1.11
Case-control study of high risk occupations for bladder cancer in New Zealand. Int J Cancer (2008) 1.09
Differences in citation rates by country of origin for papers published in top-ranked medical journals: do they reflect inequalities in access to publication? J Epidemiol Community Health (2009) 1.09
Point: Incident Exposures, Prevalent Exposures, and Causal Inference: Does Limiting Studies to Persons Who Are Followed From First Exposure Onward Damage Epidemiology? Am J Epidemiol (2015) 1.08
Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health (2005) 1.08
Occurrence of alternative flame retardants in indoor dust from New Zealand: indoor sources and human exposure assessment. Chemosphere (2012) 1.07
Selection bias and patterns of confounding in cohort studies: the case of the NINFEA web-based birth cohort. J Epidemiol Community Health (2011) 1.06
The hygiene hypothesis in allergy and asthma: an update. Curr Opin Allergy Clin Immunol (2013) 1.05
Sample selection and validity of exposure-disease association estimates in cohort studies. J Epidemiol Community Health (2010) 1.05
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Cancer incidence in four pacific countries: Tonga, Fiji Islands, Cook Islands and Niue. Pac Health Dialog (2011) 1.02
Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology (2013) 1.02
Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Statistical foundations for model-based adjustments. Annu Rev Public Health (2015) 1.01
Motor vehicle traffic crashes involving Maori. N Z Med J (2004) 1.00
Mortality from lung cancer in workers exposed to sulfur dioxide in the pulp and paper industry. Environ Health Perspect (2002) 1.00
Social class mortality differences in Maori and non-Maori men aged 15-64 during the last two decades. N Z Med J (2002) 0.99
Cohort profile: the Boston Area Community Health (BACH) survey. Int J Epidemiol (2012) 0.99
Comment on 'Performance analysis in football: a critical review and implications for future research'. J Sports Sci (2013) 0.99
Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med (2006) 0.98
Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: a multicenter study in Europe. Occup Environ Med (2009) 0.98
Socio-economic position is more than just NZDep. N Z Med J (2002) 0.98
Missing heritability in genome-wide association study research. Nat Rev Genet (2010) 0.98
Cancer in Pacific people in New Zealand: a descriptive study. Pac Health Dialog (2004) 0.98
Exposure and dose modelling in occupational epidemiology. Occup Environ Med (2007) 0.97
Incidence rates in dynamic populations. Int J Epidemiol (2012) 0.95
Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand. N Z Med J (2008) 0.94
Respiratory symptoms in children living near busy roads and their relationship to vehicular traffic: results of an Italian multicenter study (SIDRIA 2). Environ Health (2009) 0.93
Regional variations in asthma hospitalisations among Maori and non-Maori. N Z Med J (2004) 0.93
Lung cancer and occupation: A New Zealand cancer registry-based case-control study. Am J Ind Med (2010) 0.92
Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diabetes Res Clin Pract (2006) 0.92
Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study. BMC Cancer (2011) 0.91
The epidemiology of breast cancer in Maori women in Aotearoa New Zealand: implications for screening and treatment. N Z Med J (2005) 0.91
Prognostic factors in women with breast cancer: inequalities by ethnicity and socioeconomic position in New Zealand. Cancer Causes Control (2007) 0.90
Bayesian methods for early detection of changes in childhood cancer incidence: trends for acute lymphoblastic leukaemia are consistent with an infectious aetiology. Eur J Cancer (2005) 0.90
Determinants of non-response in an occupational exposure and health survey in New Zealand. Aust N Z J Public Health (2011) 0.90
Demographic differences in stage at diagnosis and cervical cancer survival in New Zealand, 1994-2005. J Womens Health (Larchmt) (2009) 0.90
Massive haemoptysis due to aortobronchial fistula caused by pulmonary hydatidosis. Med J Aust (2009) 0.89
Selecting appropriate study designs to address specific research questions in occupational epidemiology. Occup Environ Med (2007) 0.89
Comorbidity among patients with colon cancer in New Zealand. N Z Med J (2011) 0.89
Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY Study. Am J Epidemiol (2013) 0.89
Quantitative estimates of work-related death, disease and injury in New Zealand. Scand J Work Environ Health (2005) 0.88
Targeting of multiple signaling pathways by the Hsp90 inhibitor SNX-2112 in EGFR resistance models as a single agent or in combination with erlotinib. Oncol Res (2009) 0.88
Occupational mortality studies: still relevant in the 21st century. Occup Environ Med (2010) 0.87
Do healthy and unhealthy behaviours cluster in New Zealand? Aust N Z J Public Health (2007) 0.87